BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 9059934)

  • 1. A rodent model of in utero chimeric tolerance induction.
    Yuh DD; Gandy KL; Hoyt G; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1997 Feb; 16(2):222-30. PubMed ID: 9059934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to cardiac allografts induced in utero with fetal liver cells.
    Yuh DD; Gandy KL; Hoyt G; Reitz BA; Robbins RC
    Circulation; 1996 Nov; 94(9 Suppl):II304-7. PubMed ID: 8901765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal induction of immunotolerance to cardiac and pulmonary allografts.
    Yuh DD; Gandy KL; Reitz BA; Hoyt G; Robbins RC
    J Thorac Cardiovasc Surg; 1997 Jul; 114(1):64-75. PubMed ID: 9240295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
    Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW
    Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different immune effects on cardiac allografts and xenografts induced by neonatal intrathymic inoculation with allogeneic and xenogeneic antigens.
    Shen Z; Pelletier S; Mohiuddin M; Yokoyama H; Reiss GR; DiSesa VJ
    J Heart Lung Transplant; 1996 Oct; 15(10):1034-8. PubMed ID: 8913921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of chimerism in the rat tolerant to a renal allograft.
    Naar JD; Fisher RA; Saggi BH; Wakely PE; Tawes JW; Posner MP
    J Surg Res; 1998 Jul; 77(2):179-86. PubMed ID: 9733606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: analysis of the immune status.
    Yamaguchi Y; Mori K; Bollinger RR
    J Clin Lab Immunol; 1990 Jun; 32(2):59-66. PubMed ID: 1967040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious tolerance mediated by CD8+ T-suppresor cells after UV-B-irradiated donor-specific transfusion and rat heart transplantation.
    Witkowski P; Liu JW; Jin MX; Liu Z; Suciu-Foca N; Hardy MA
    Transplant Proc; 2005; 37(1):43-5. PubMed ID: 15808541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Infectious tolerance" develops after the spontaneous acceptance of Lewis-to-Dark Agouti rat liver transplants.
    Kataoka M; Margenthaler JA; Ku G; Eilers M; Flye MW
    Surgery; 2003 Aug; 134(2):227-34. PubMed ID: 12947322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injection of allogeneic bone marrow cells into the portal vein of swine in utero.
    Rubin JP; Cober SR; Butler PE; Randolph MA; Gazelle GS; Ierino FL; Sachs DH; Lee WP
    J Surg Res; 2001 Feb; 95(2):188-94. PubMed ID: 11162044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microchimerism does not induce tolerance after in utero transplantation and may lead to the development of alloreactivity.
    Carrier E; Gilpin E; Lee TH; Busch MP; Zanetti M
    J Lab Clin Med; 2000 Sep; 136(3):224-35. PubMed ID: 10985501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of specific tolerance to small-bowel allografts.
    Orloff MS; Fallon MA; DeMara E; Coppage ML; Leong N; Cerilli J
    Surgery; 1994 Aug; 116(2):222-8. PubMed ID: 8047988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts.
    Li S; Salgar SK; Thanikachalam M; Murdock AD; Gammie JS; Demetris AJ; Zeevi A; Pham SM
    J Surg Res; 2006 Dec; 136(2):238-46. PubMed ID: 17046021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of donor-specific tolerance to cardiac xenografts in utero.
    Tanaka SA; Hiramatsu T; Oshitomi T; Imai Y; Koyanagi H
    J Heart Lung Transplant; 1998 Sep; 17(9):888-91. PubMed ID: 9773861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal inoculation with donor cells in cardiac xenotransplantation.
    Shen Z; Mohiuddin M; DiSesa VJ
    Ann Thorac Surg; 1996 Nov; 62(5):1360-3. PubMed ID: 8893569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
    J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.